(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

APEXBIO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

APEXBIO

ST13

US500000088590882

Class

5, 10

Filing

88590882

Registration

6081902

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

12/16/2025

Trademark type

Word

Nice classes

5, 10

Filing date

08/23/2019

Registration date

06/16/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/15/2025

Last transaction

12/16/2025

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

11/13/2017

First use in commerce

04/03/2020

Drawing code

4

Owner type

03

Owner location

Hsinchu City, TW

Examiner

GIPSOV,MARYNA K

Current location

Historical data usage

Holders and representatives

Holders

A. C. (pessoa física)

Representatives

Jeannine Rittenhouse IPHORGAN LTD.

Technical classification

Nice Classes

Class 5Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Reagent strips for medical diagnostic use; glucose control solution for medical diagnostic use; uric acid control solution for medical diagnostic use; hemoglobin testing agents for medical diagnostic use; cholesterol testing agents for medical diagnostic use; lactic acid testing agents for medical diagnostic use

Class 10

Testing and analytical apparatus for medical diagnostic use in the field of blood biochemistry; testing and analytical apparatus for medical diagnostic use in the field of urine biochemistry; blood uric monitoring apparatus for medical diagnostic use; blood glucose monitoring apparatus for medical use; lancets; hemoglobin testing apparatus for medical diagnostic use; cholesterol testing apparatus for medical diagnostic use; lactic acid testing apparatus for medical diagnostic use

Publications

History of USPTO decisions and trademark events.

28 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

12/15/2025

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

12/15/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/15/2025

E815

TEAS SECTION 8 & 15 RECEIVED

09/10/2025

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

06/16/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

06/16/2020

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

05/15/2020

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

05/14/2020

SUPC

STATEMENT OF USE PROCESSING COMPLETE

05/12/2020

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

05/11/2020

IUAF

USE AMENDMENT FILED

04/27/2020

EISU

TEAS STATEMENT OF USE RECEIVED

04/27/2020

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

04/21/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/25/2020

PUBO

PUBLISHED FOR OPPOSITION

02/25/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/05/2020

ALIE

ASSIGNED TO LIE

01/21/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/17/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

01/17/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

01/17/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

01/17/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

01/17/2020

GPRN

NOTIFICATION OF PRIORITY ACTION E-MAILED

12/02/2019

GPRA

PRIORITY ACTION E-MAILED

12/02/2019

CPRA

PRIORITY ACTION WRITTEN

12/02/2019

DOCK

ASSIGNED TO EXAMINER

11/22/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/07/2019

NWAP

NEW APPLICATION ENTERED

08/27/2019

Continuous trademark protection

Get notified about every new filing that threatens APEXBIO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.